CytomX

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CytomX and other ETFs, options, and stocks.

About CTMX

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W.

CEO

Sean A. McCarthy

CEOSean A. McCarthy

Employees

121

Employees121

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2010

Founded2010

Employees

121

Employees121

CTMX Key Statistics

Market cap

319.11M

Market cap319.11M

Price-Earnings ratio

3.43

Price-Earnings ratio3.43

Dividend yield

—

Dividend yield—

Average volume

2.68M

Average volume2.68M

High today

$2.03

High today$2.03

Low today

$1.93

Low today$1.93

Open price

$2.01

Open price$2.01

Volume

1.89M

Volume1.89M

52 Week high

$3.10

52 Week high$3.10

52 Week low

$0.40

52 Week low$0.40

CTMX News

TipRanks 1d

CytomX Therapeutics assumed with an Overweight at Barclays

Barclays analyst Etzer Darout assumed coverage of CytomX Therapeutics (CTMX) with an Overweight rating and $3.50 price target The firm sees a positive risk/rewa...

Analyst ratings

86%

of 7 ratings

Buy

85.7%

Hold

14.3%

Sell

People also own

Based on the portfolios of people who own CTMX. This list is generated using Robinhood data, and it’s not a recommendation.